Raymond Pagliarini

5.3k citations

20 papers · 2.3k indexed · h-index 16

Cell Biology top 2%
- Hippo pathway signaling and YAP/TAZ 2
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 2
Aging top 5%
Molecular Biology top 5%
- Protein Degradation and Inhibitors 3
- Mitochondrial Function and Pathology 2
- ATP Synthase and ATPases Research 2
- Epigenetics and DNA Methylation 2
Oncology top 5%
Genetics
- Glioma Diagnosis and Treatment 3

Co-authors: Tian Xu Tatsushi Igaki William R. Sellers Wenlin Shao Alexandra Grassian Ajay Srivastava Franklin Chung Nickolas Papadopoulos
Cited by: Cell Biology Cancer Research Aging
Journals: Science (1 paper)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States Switzerland China

In The Last Decade

Raymond Pagliarini

19 papers receiving 2.3k citations

Peers

Countries citing papers authored by Raymond Pagliarini

Since Specialization

Citations

This map shows the geographic impact of Raymond Pagliarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Pagliarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Pagliarini more than expected).

Fields of papers citing papers by Raymond Pagliarini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Pagliarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Pagliarini. The network helps show where Raymond Pagliarini may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raymond Pagliarini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raymond Pagliarini Line = papers co-authored together Raymond Pagliarini links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of STX-721, a Covalent, Potent, and Highly Mutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatment of Non-Small Cell Lung Cancer Journal of Medicinal Chemistry ·Benjamin C. Milgram,Deanna R. Borrelli,Natasja Brooijmans,Jack A. Henderson,Brendan J. Hilbert,Michael R. Huff,Takahiro Ito,Erica L. Jackson,Philip Jonsson,Brendon Ladd,Erin O’Hearn,Raymond Pagliarini,Simon Roberts,Sébastien Ronseaux,Darrin D. Stuart,Weixue Wang,Angel Guzman-Perez	2025	0
2	Patient-derived glioblastoma cultures as a tool for small-molecule drug discovery Oncotarget ·Ling F. Ye,Eduard Reznik,Joshua M. Korn,Fallon Lin,Guizhi Yang,Kimberly Malesky,Hui Gao,Alice Loo,Raymond Pagliarini,Tom Mikkelsen,Donald C. Lo,Ana C. deCarvalho,Brent R. Stockwell	2020	15
3	Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss Nature Medicine ·Huayang Liu,Javad Golji,Lauren K. Brodeur,Franklin Chung,Julie Chen,Rosalie deBeaumont,Caroline Bullock,Michael D. Jones,Gráinne Kerr,Li Li,Daniel P. Rakiec,Michael R. Schlabach,Sosathya Sovath,Joseph D. Growney,Raymond Pagliarini,David A. Ruddy,Kenzie D. MacIsaac,Joshua M. Korn,E. Robert McDonald	2018	221
4	Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure EMBO Reports ·Raymond Pagliarini,Wenlin Shao,William R. Sellers	2015	179
5	IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism Cancer Research ·Alexandra Grassian,Seth J. Parker,Shawn M. Davidson,Ajit S. Divakaruni,Courtney R. Green,Xiamei Zhang,Kelly L. Slocum,Minying Pu,Fallon Lin,Chad Vickers,Carol Joud-Caldwell,Franklin Chung,Hong Yin,Erika D. Handly,Christopher Straub,Joseph D. Growney,Matthew G. Vander Heiden,Anne N. Murphy,Raymond Pagliarini,Christian M. Metallo	2014	211
6	A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein Molecular Cancer Therapeutics ·Marius S. Pop,Nicolas Stransky,Colin W. Garvie,Jean‐Philippe Theurillat,Emily C. Hartman,Timothy A. Lewis,Cheng Zhong,Elizabeth K. Culyba,Fallon Lin,Douglas S. Daniels,Raymond Pagliarini,Lucienne Ronco,Angela N. Koehler,Levi A. Garraway	2014	49
7	IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism DSpace@MIT (Massachusetts Institute of Technology) ·Alexandra Grassian,Seth J. Parker,Ajit S. Divakaruni,C. R. Green,X. Zhang,Kelly L. Slocum,Minying Pu,Fallon Lin,Chad Vickers,Carol Joud-Caldwell,Florence H. T. Chung,Hong Yin,Erika D. Handly,Christopher Straub,Joseph D. Growney,Anne N. Murphy,Raymond Pagliarini,Christian M. Metallo,Shawn M. Davidson,Matthew G. Vander Heiden	2014	83
8	Identification of Mixed Lineage Leukemia 1(MLL1) Protein as a Coactivator of Heat Shock Factor 1(HSF1) Protein in Response to Heat Shock Protein 90 (HSP90) Inhibition Journal of Biological Chemistry ·Yaoyu Chen,Jinyun Chen,Jianjun Yu,Guizhi Yang,Emilia Temple,Fred Harbinski,Hui Gao,Christopher J. Wilson,Raymond Pagliarini,Wenlai Zhou	2014	12
9	Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma Current Opinion in Gastroenterology ·Alexandra Grassian,Raymond Pagliarini,Derek Y. Chiang	2014	42
10	TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation Oncogene ·Zineb Mounir,Fallon Lin,Virginia Lin,Joshua M. Korn,Yi Yu,Ricardo A. Valdez,Olulanu H. Aina,Gilles Buchwalter,Aron B. Jaffe,Manav Korpal,Ping Zhu,Myles Brown,Robert D. Cardiff,Jennifer L. Rocnik,Yinhui Yang,Raymond Pagliarini	2014	46
11	Abstract LB-139: IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism Cancer Research ·Alexandra Grassian,Seth J. Parker,Shawn M. Davidson,Ajit S. Divakaruni,Courtney Green,Xiamei Zhang,Kelly L. Slocum,Minying Pu,Fallon Lin,Chad Vickers,Carol Joud-Caldwell,Franklin Chung,Hong Yin,Erika D. Handly,Christopher Straub,Joseph D. Growney,Matt Vander Heiden,Anne N. Murphy,Raymond Pagliarini,Christian M. Metallo	2014	2
12	Targeting HSF1 sensitizes cancer cells to HSP90 inhibition Oncotarget ·Yaoyu Chen,Jinyun Chen,Alice Loo,Savina Jaeger,Linda Bagdasarian,Jianjun Yu,Franklin Chung,Joshua M. Korn,David A. Ruddy,Ribo Guo,Margaret E. McLaughlin,Fei Feng,Ping Zhu,Frank Stegmeier,Raymond Pagliarini,Dale Porter,Wenlai Zhou	2013	49
13	Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth Oncotarget ·Jinyun Chen,Franklin Chung,Guizhi Yang,Minying Pu,Hui Gao,Wei Jiang,Hong Yin,Vladimı́r Čápka,Shailaja Kasibhatla,Bryan Laffitte,Savina Jaeger,Raymond Pagliarini,Yaoyu Chen,Wenlai Zhou	2013	64
14	Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT) Journal of Biological Chemistry ·Alexandra Grassian,Fallon Lin,Rosemary Barrett,Yue Liu,Wei Jiang,Manav Korpal,Holly Astley,Daniel P. Gitterman,Thomas Henley,Rob Howes,Julian Levell,Joshua M. Korn,Raymond Pagliarini	2012	83
15	PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling Cancer Research ·Ensar Halilovic,Qing‐Bai She,Qing Ye,Raymond Pagliarini,William R. Sellers,David B. Solit,Neal Rosen	2010	133
16	A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53 Proceedings of the National Academy of Sciences ·Surojit Sur,Raymond Pagliarini,Fred Bunz,Carlo Rago,Luis A. Díaz,Kenneth W. Kinzler,Bert Vogelstein,Nickolas Papadopoulos	2009	230
17	Basement membrane remodeling is essential for Drosophila disc eversion and tumor invasion Proceedings of the National Academy of Sciences ·Ajay Srivastava,(unknown),Tatsushi Igaki,Raymond Pagliarini,Tian Xu	2007	170
18	Loss of Cell Polarity Drives Tumor Growth and Invasion through JNK Activation in Drosophila Current Biology ·Tatsushi Igaki,Raymond Pagliarini,Tian Xu	2006	300
19	A Genetic Screen in Drosophila for Metastatic Behavior Science ·Raymond Pagliarini,Tian Xu	2003	436
20	Analyzing the Function of Tumor Suppressor Genes Using a Drosophila Model Humana Press eBooks ·Raymond Pagliarini,Ana T. Quiñones,Tian Xu	2003	11

About Raymond Pagliarini

Raymond Pagliarini is a scholar working on Cancer Research, Genetics and Cell Biology, having authored 20 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Glioma Diagnosis and Treatment (3 papers), Protein Degradation and Inhibitors (3 papers), Mitochondrial Function and Pathology (2 papers), ATP Synthase and ATPases Research (2 papers), Epigenetics and DNA Methylation (2 papers), MicroRNA in disease regulation (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Cell Biology (725 citations), Cancer Research (525 citations) and Aging (45 citations). Raymond Pagliarini has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Tian Xu, Tatsushi Igaki, William R. Sellers, Wenlin Shao, Alexandra Grassian, Ajay Srivastava, Franklin Chung, Nickolas Papadopoulos, Carlo Rago and Surojit Sur. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact